LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Purchased by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP increased its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 87.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,524,529 shares of the company's stock after buying an additional 1,643,390 shares during the quarter. Dimensional Fund Advisors LP owned 0.92% of LifeStance Health Group worth $25,977,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in LFST. Blue Trust Inc. raised its holdings in shares of LifeStance Health Group by 124.4% in the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock worth $27,000 after buying an additional 2,122 shares during the last quarter. R Squared Ltd purchased a new stake in LifeStance Health Group during the 4th quarter valued at about $80,000. Cibc World Markets Corp purchased a new position in shares of LifeStance Health Group in the fourth quarter worth about $96,000. Forum Financial Management LP acquired a new stake in shares of LifeStance Health Group during the fourth quarter worth about $110,000. Finally, Handelsbanken Fonder AB purchased a new stake in LifeStance Health Group in the fourth quarter valued at approximately $128,000. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider Lisa K. Miller sold 18,845 shares of the firm's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the completion of the transaction, the insider now directly owns 339,810 shares in the company, valued at $2,344,689. This trade represents a 5.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 3.20% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on LFST. William Blair reissued an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. KeyCorp began coverage on LifeStance Health Group in a research report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price target for the company. Finally, Canaccord Genuity Group initiated coverage on LifeStance Health Group in a report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, three have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, LifeStance Health Group presently has an average rating of "Moderate Buy" and an average price target of $8.30.

LifeStance Health Group Trading Down 1.4 %

LFST traded down $0.08 during trading hours on Friday, reaching $5.73. The company's stock had a trading volume of 2,860,646 shares, compared to its average volume of 1,644,777. The stock has a market cap of $2.23 billion, a PE ratio of -22.04 and a beta of 1.30. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $8.61. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The business's 50-day moving average is $6.70 and its 200-day moving average is $7.25.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.